• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home The Classics Gastroenterology Classics

Prednisolone vs placebo in severe alcoholic hepatitis [Classics Series]

byShaidah Deghan, MSc. MDandAndrew Cheung, MD MBA
May 12, 2015
in Gastroenterology Classics, The Classics
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Compared to placebo, treating patients with severe alcoholic hepatitis with 28 days of prednisolone significantly improved the short-term survival up to 6 months.

2. There remains significant controversy surrounding the use of glucocorticoids in managing severe alcoholic hepatitis, as numerous other trials have demonstrated no mortality benefit, but significantly higher risk of infection with glucocorticoid therapy.

Original Date of Publication: February 1992

Study Rundown: Alcoholic hepatitis is a form of acute liver disease that may develop in individuals with prolonged, heavy alcohol intake. In patients with alcoholic hepatitis, conventional management consists of abstinence from alcohol, correction of dietary deficiencies, and supportive care. Maddrey discriminant function is a prognostic tool that is used to assess the severity of alcoholic hepatitis. Patients with scores ≥32 are termed severe alcoholic hepatitis, and experience significantly higher rates of morbidity and mortality than those with less severe disease. Prior to this study, several randomized trials had explored using glucocorticoids in managing alcoholic hepatitis, though results were conflicting. Meta-analyses of these trials suggested that there may be a benefit of using glucocorticoids in patients with severe disease. Thus, the purpose of this trial was to determine whether treating patients with severe alcoholic hepatitis with glucocorticoids would significantly reduce mortality as compared with placebo. In summary, corticosteroid therapy was found to significantly reduce mortality in patients with severe alcoholic hepatitis, as characterized by Maddrey discriminant function ≥32 or hepatic encephalopathy. Subsequent studies of glucocorticoids have continued to produce conflicting results, and there remains controversy surrounding their use in managing alcoholic hepatitis, as other studies have demonstrated significantly higher rates of infection with prednisolone therapy. While pentoxifylline has also been studied in severe alcoholic hepatitis, the results describing their effects have also been conflicting.

Click to read the study in the NEJM (New England Journal of Medicine)

EvidencePulse™by 2 Minute Medicine®

How does Prednisolone vs placebo in severe alcoholic hepatitis apply to your patient?

Describe your patient and EvidencePulse weighs this trial against later evidence and current guidelines, with citations.

Ask EvidencePulse

For a fuller review of the evidence, Deep research is a core feature of 2MM Max.

In-Depth [randomized controlled study]: A total of 65 participants were selected from 2 hospitals in France and randomized to treatment with prednisolone 40 mg daily or placebo for 28 days. Patients unable to take oral medications received intravenous infusions of prednisolone or placebo. Patients were eligible for the trial if they had biopsy-proven alcoholic hepatitis and severe alcoholic hepatitis (i.e., spontaneous hepatic encephalopathy or Maddrey discriminant score ≥32). Exclusion criteria included gastrointestinal bleeding or bacterial infection that could not effectively be treated within the first 48 hours. The primary endpoint was mortality within 2 months.

The two groups did not differ with regards to sex, age, duration of hospitalization before entry into the study, the presence of ascities, spontaneous hepatic encephalopathy, or esophageal varices. Survival in the prednisolone group was 88±5% and 88±5% at 1 and 2 months, respectively, compared to 62±9% and 45±8% in the placebo group for the same timepoints. Survival was significantly better in patients treated with corticosteroid than those taking placebo, regardless of the presence or absence of encephalopathy (adjusted log-rank test 9.9; p = 0.0017). The cumulative six-month survival rates were 84±6% in the prednisolone group and 45±9% in the placebo group (low-rank test 9.5; p = 0.002).

Trials since this one

What later trials found on the same question.

  1. 1994

    Transjugular intrahepatic portosystemic shunt effective in preventing recurrent variceal hemorrhage In The Classics

    In patients with recurrent variceal bleeding secondary to portal hypertension, the use of transjugular intrahepatic portosystemic shunt (TIPS) demonstrated high efficacy in preventing variceal re-bleeds.

  2. 1999

    Albumin in cirrhotic patients with spontaneous bacterial peritonitis In The Classics

    In cirrhotic patients with spontaneous bacterial peritonitis, albumin infusion on days 1 and 3 of treatment in addition to antibiotics significantly reduces the risk of developing renal impairment and mortality when…

6 more since 1992

2MM+ See every trial since Prednisolone vs placebo in severe alcoholic hepatitis

2MM+ shows the full timeline of later trials on this question, with what each one found, and lets you save trials to reading lists for rounds, journal club and boards.

See 2MM+ plans Sign in

Citation: Ramond MJ, Poynard T, Rueff B, Mathurin P, Théodore C, Chaput JC, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 1992 Feb 20;326(8):507-12. doi: 10.1056/nejm199202203260802. PMID: 1531090.

© 2015 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: PD

Tags: Alcoholcorticosteroidliver disease

New landmark trials, every weekday

The free 2 Minute Medicine Daily Brief: practice-changing studies summarized by physicians, in your inbox.

Your subscription opens securely in a new tab.

More Gastroenterology and hepatology Classics

Previous Post

Self-identified lesbians associated with decreased HPV vaccination

Next Post

Mediterranean diet may reduce age-related neurocognitive decline

Next Post

Mediterranean diet may reduce age-related neurocognitive decline

2 Minute Medicine Rewind May 3 – May 10, 2015

Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma

HPV vaccinations for boys can increase benefits of vaccination program

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Removing Race and Ethnicity From Dialysis Mortality Risk Adjustment Changes Facility Performance Rankings
  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.